What's breaking now, across thousands of outlets.
A Dutch court barred Merck from selling subcutaneous Keytruda in several European countries. Elsewhere, an Insmed executive ended a seven-year run and two startups secured venture cash.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Plus news about RevMed, Tang Capital, GSK and AmyriAD Therapeutics. Nuvig Therapeutics ends one of two trials: The biotech axed a Phase 2 study of its candidate NVG-2089 in patients with chronic…
The Bibiani Anhwiaso Bekwai Municipal Health Directorate in the Western North Region has recorded more than 200 dog bite cases and four rabies-related deaths between January and October this year.
Taking opioids for years does not seem to reduce pain or improve functioning in people with chronic back pain, according to a new Northwestern University study that compared 70 long-term opioid users…
A psychiatrist, Dr Abayomi Olajide, has urged the government to declare a state of emergency on substance abuse, warning it is worsening Nigeria’s mental h Read More…
Here's how to keep the friendship while skipping the germs.
A €308,550 design contract has been awarded, but the planned €4.1 million facility is unlikely to open before 2029. Plans for Redován’s long-awaited health centre have taken a significant step forward…
